06/17/2019
7:23 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) |  |
05/16/2019
4:20 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
4:01 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2019
8:27 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2019
8:44 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2019
8:24 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2019
10:33 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2019
8:31 PM | Cellular Biomedicine Group (Filer)
| Form 424B5
| |
03/22/2019
4:29 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2019
3:20 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2019
3:11 PM | Cellular Biomedicine Group (Filer)
| Form 424B5
| |
03/15/2019
4:13 PM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
03/15/2019
4:11 PM | Cellular Biomedicine Group (Filer)
| Form DEF 14A
| |
03/01/2019
10:05 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
4:01 PM | Cellular Biomedicine Group (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2019
8:53 PM | Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/14/2019
8:50 PM | Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/14/2019
8:48 PM | Cellular Biomedicine Group (Issuer)
Yao Yihong (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/25/2019
3:45 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2019
5:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2019
7:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2018
3:11 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2018
1:10 PM | Cellular Biomedicine Group (Subject)
Dangdal International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
11/06/2018
5:26 AM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2018
7:07 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2018
8:16 AM | Cellular Biomedicine Group (Filer)
| Form 424B3
| |
10/22/2018
11:15 PM | Cellular Biomedicine Group (Filer)
| Form EFFECT
| |
10/18/2018
3:13 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
10/18/2018
3:06 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
10/10/2018
6:11 PM | Cellular Biomedicine Group (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/10/2018
7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2018
4:27 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2018
7:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2018
3:33 PM | Cellular Biomedicine Group (Subject)
NOVARTIS PHARMA AG (Filed by)
| Form SC 13G
| |
09/27/2018
6:45 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2018
8:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2018
3:10 PM | Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2018
3:10 PM | Au Chun Kwok Alan (Reporting)
Cellular Biomedicine Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2018
3:10 PM | Cellular Biomedicine Group (Issuer)
Patel Nadir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2018
3:10 PM | Belmont Terry (Reporting)
Cellular Biomedicine Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2018
3:10 PM | Cellular Biomedicine Group (Issuer)
Ji Gang Jacky (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2018
3:10 PM | Cellular Biomedicine Group (Issuer)
Zhou Hansheng (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2018
4:27 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2018
8:11 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2018
7:42 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
7:33 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2018
3:05 PM | Cellular Biomedicine Group (Issuer)
Liu Wen Tao (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2018
3:11 PM | Cellular Biomedicine Group (Filer)
| Form 424B3
| |
04/09/2018
11:15 PM | Cellular Biomedicine Group (Filer)
| Form EFFECT
| |
04/02/2018
3:17 PM | Cellular Biomedicine Group (Filer)
| Form S-3/A
| |
03/16/2018
8:56 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2018
11:40 AM | Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2018
4:29 PM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
03/12/2018
4:15 PM | Cellular Biomedicine Group (Filer)
| Form DEF 14A
| |
03/06/2018
12:31 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2018
3:51 PM | Cellular Biomedicine Group (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2018
2:26 PM | Cellular Biomedicine Group (Subject)
Full Moon Resources Ltd (Filed by)
| Form SC 13G/A
| |
02/15/2018
5:02 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
12:14 PM | Cellular Biomedicine Group (Subject)
Sailing Capital Overseas Investments Fund, LP (Filed by)
| Form SC 13D
| |
02/13/2018
5:05 PM | Cellular Biomedicine Group (Issuer)
Meng Xia (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/13/2018
4:37 PM | Cellular Biomedicine Group (Issuer)
Hau Bosun (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/02/2018
10:57 AM | Cellular Biomedicine Group (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/01/2018
3:46 PM | Cellular Biomedicine Group (Subject)
Maplebrook Ltd (Filed by)
| Form SC 13G
| |
01/31/2018
7:47 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2017
3:32 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2017
4:08 PM | Cellular Biomedicine Group (Issuer)
Yao Yihong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2017
4:08 PM | Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2017
4:08 PM | Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2017
3:06 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
